Strong Growth Ahead: G-Protein Coupled Receptors Market Size To Grow At Arecord 7% Cagr By 2029

The G-Protein Coupled Receptors Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

How Big Is the G-Protein Coupled Receptors Market Size Expected to Be by 2034?
In recent times, the market size for G-protein coupled receptors has seen robust growth. Projected to expand from $3.2 billion in 2024 to $3.41 billion in 2025, it will have a compound annual growth rate (CAGR) of 6.6%. The substantial growth observed in the historical period is credited to advancements in drug discovery, FDA approvals, discoveries in genomics, emerging markets, market consolidation, and a growing aging population.

The market for G-protein coupled receptors is predicted to experience robust growth in the coming years, with an estimated value of $4.46 billion by 2029, reflecting a compound annual growth rate (CAGR) of 7.0%. Factors contributing to this growth over the forecast period include personalized medicine approaches, heightened attention to rare diseases, the application of artificial intelligence in drug discovery, a patient-focused approach to drug development, as well as environmental and social factors including biosimilar market expansion. The period is also expected to witness advancements in biotechnology, increased research and development investments, technological innovations, collaborations and partnerships, and digital therapeutics.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11976

What Are the Emerging Segments Within the G-Protein Coupled Receptors Market?
The G-protein coupled receptors market covered in this report is segmented -

1) By Product: Cell Lines, Detection Kits, Cell Culture Reagents, Ligands
2) By Assay: CAMP Functional Assays, Calcium Functional Assays, ß-Arrestin Functional Assays, Radioligand Binding And GTP?S Functional Assays, Internalization Assays, Trafficking Assays
3) By Applications: Cancer Research, CNS Research, Metabolic Research, Cardiovascular Research, Inflammation Research, Respiratory Research, Other Applications

Subsegments:
1) By Cell Lines: GPCR-Expressing Cell Lines, Stable And Transient Cell Lines
2) By Detection Kits: ELISA Kits, High-Throughput Screening Kits, Reporter Gene Assays
3) By Cell Culture Reagents: Media And Supplements, Transfection Reagents, Growth Factors
4) By Ligands: Agonists, Antagonists, Inverse Agonists

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11976&type=smp

What Long-Term Drivers Are Shaping G-Protein Coupled Receptors Market Trends?
The escalating incidence of cancer is projected to fuel the expansion of the G-protein-coupled receptors market in the future. Cancer, a disease where abnormal cells multiply and spread uncontrollably, can infect surrounding tissues. The lymphatic and vascular systems also serve as pathways for the propagation of these cancer cells. GPCRs manage the activities recognized as cancer's defining traits, such as proliferative signaling, replicative immortality, evasion of growth suppressors, resistance to cell death, and initiation of invasion and spread. For example, the American Cancer Society reported in January 2023 that the number of new cancer cases diagnosed in the US in 2023 rose to 1,958,310, up from the estimated 1.9 million new cases in 2022. Consequently, the growing incidence of cancer is bolstering the growth of the G-protein coupled receptors market.

Who Are the Top Competitors in Key G-Protein Coupled Receptors Market Segments?
Major companies operating in the G-protein coupled receptors market include Pfizer Inc., Roche Holding AG, AbbVie Inc., Bayer AG, Novartis International AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca Plc, GlaxoSmithKline Plc, Danaher Corporation, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Merck KGaA, Boehringer Ingelheim, Teva Pharmaceutical Industries Ltd., Daiichi Sankyo Company Limited, Thermo Fisher Scientific Inc., Perkin Elmer Inc., Qiagen N.V., Bio-Techne Corporation, Abcam PLC, Cara Therapeutics Inc., Sosei Heptares Ltd., Eurofins DiscoverX Corporation, Crinetics Pharmaceuticals Inc., Domain Therapeutics SA, Addex Pharmaceuticals Ltd., Escient Pharmaceuticals Inc., Structure Therapeutics, Septerna

What G-Protein Coupled Receptors Market Trends Are Gaining Traction Across Different Segments?
One noticeable trend in the G-protein-coupled receptor (GPCR) market is the increased investment in advancing GPCR screening and antibody technology. Main players in the GPCR industry are concentrating their efforts on securing funding for the development of GPCR-related drugs and health technologies. For example, LifeArc Ventures, a British venture capital firm, invested $16 million in Maxion Therapeutics, a British pharmaceutical discovery firm, in February 2023. The main aim of this investment is to propel the growth of antibody treatments for previously incurable ion channel and GPCR-related illnesses using the specialized KnotBody methodology. The KnotBody approach allows for the identification of biologicals against ion channels and GPCRs through the utilization of naturally present cysteine-rich mini proteins. In addition, US-based biotech firm Septerna Inc. announced its establishment and a Series A funding round of $100 million. This capital will support the development of their new line of innovative GPCR-directed medicine programs, backed by the Native Complex Platform, and span a wide range of therapeutic sectors.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/g-protein-coupled-receptors-global-market-report

Which Regions Are Becoming Hubs for G-Protein Coupled Receptors Market Innovation?
North America was the largest region in the G-protein coupled receptors market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the G-protein coupled receptors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the G-Protein Coupled Receptors Market?
2. What is the CAGR expected in the G-Protein Coupled Receptors Market?
3. What Are the Key Innovations Transforming the G-Protein Coupled Receptors Industry?
4. Which Region Is Leading the G-Protein Coupled Receptors Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.